Morgan Stanley maintains EQT at Overweight, lowers price target to $66 from $67
Morgan Stanley kept its Overweight rating on EQT but reduced its price target to $66 from $67. The new target suggests a 31.1% upside from the Nov 17 close of $50.36. Recent analyst price targets for EQT range from $53 to $77.
How this was made

The 30-second read
Why it matters
For EQT, the actionable signal is limited because the rating stays Overweight and the target change is small; it mainly affects valuation expectations rather than near-term fundamentals.
Market read
Traders may treat this as a minor sentiment input rather than a standalone catalyst.
What to watch
The article does not provide the thesis behind the target change, so traders may need to check the underlying analyst note for drivers (commodity assumptions, balance-sheet outlook, or volume/cost estimates).
Background
The piece is an analyst rating maintenance update from Morgan Stanley, not a company disclosure.
Ticker impact
Morgan Stanley maintained EQT at Overweight and cut its price target to $66 from $67, signaling a modest valuation reset.
Likely mild downside bias as the market digests the lower target, though the unchanged Overweight rating should limit downside follow-through.
The only disclosed change is a $1 reduction in the price target; no new fundamentals, guidance, or event risk is mentioned.
Market effects
Minimal, since this is a single-name analyst target adjustment with no sector-wide catalyst described.
None indicated; the note is company-specific.
None indicated; no cross-border or macro linkage is provided.
Counterpoint
The unchanged Overweight rating may matter more than the small target cut, implying the market may largely ignore the adjustment.
Key entities
- companyEQT
Subject of the analyst action: maintained Overweight, lowered price target to $66 from $67.
- analyst_firmMorgan Stanley
Issued the rating maintenance and price-target reduction referenced in the article.

